Sex-specific Mediation of Opioid-induced Hyperalgesia by the Melanocortin-1 Receptor
Authors:
Open Access
- 1 January 2010
- journal article
- pain medicine
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 112 (1) , 181-188
Abstract
Background: N-Methyl-D-aspartate receptor antagonists reverse hyperalgesia during morphine infusion in male mice only. Because the melanocortin-1 receptor can act as a female-specific counterpart to N-methyl-D-aspartate receptors in kappa-opioid analgesic mechanisms, the authors assessed the contribution of melanocortin-1 receptors to the sex-specific mechanisms underlying morphine hyperalgesia. Methods: The tail-withdrawal test was used to compare the nociceptive responses of male and female C57BL/6J (B6) mice with those of C57BL/6J-Mc(1r(e/e)) mice, spontaneous mutants of the B6 background lacking functional melanocortin-1 receptors, during continuous morphine infusion (1.6 and 40.0 mgkg(-1) . 24 h(-1)). Separate groups of hyperalgesic B6 and outbred CD-1 mice were injected with MK-801 or MSG606, selective N-methyl-D-aspartate and melanocortin-1 receptor antagonists, respectively. Results: Morphine infusion (40.0 mg . kg(-1) . 24 h(-1)) reduced baseline withdrawal latencies by 45-55% in B6 mice of both sexes, indicating hyperalgesia; this increased nociception was manifest in male e/e mice only. Although MK-801 reversed hyperalgesia in male mice only, increasing latencies by 72%, MSG606 increased latencies by approximately 60% exclusively in females. A lower morphine infusion dose (1.6 mg . kg(-1) . 24 h(-1)) reduced baseline withdrawal latencies by 45-52% in B6 and e/e mice of both sexes, which was reversed by MK-801, but not MSG606, in both male and female B6 mice. Conclusions: The data indicate the sex-specific mediation of high-dose morphine-induced hyperalgesia by N-methyl-d-aspartate and melanocortin-1 receptors in male and female mice, respectively, suggesting a broader relevance of this known sexual dimorphism. The data further indicate that the neural substrates contributing to hyperalgesia are morphine dose-dependent.Keywords
This publication has 28 references indexed in Scilit:
- Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatmentNeuropharmacology, 2008
- Characterization of morphine-induced hyperalgesia in male and female ratsPain, 2005
- Antinociceptive and nociceptive actions of opioidsJournal of Neurobiology, 2004
- Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in ratsEuropean Journal of Pharmacology, 2001
- Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive ToleranceJournal of Neuroscience, 2001
- Pharmacology of Morphine and Morphine‐3‐glucuronide at Opioid, Excitatory Amino Acid, GABA and Glycine Binding SitesBasic & Clinical Pharmacology & Toxicology, 1994
- Morphine-3-glucuronide: Silent regulator of morphine actionsLife Sciences, 1994
- Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacementPain, 1993
- Intrathecal high dose morphine produces hyperalgesia in the ratBrain Research, 1981
- PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSEBritish Journal of Pharmacology and Chemotherapy, 1957